期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

血液透析患者血浆同型半胱氨酸的研究进展 被引量：2

下载PDF
导出
摘要 心脑血管疾病是维持性血液透析（MHD）患者最常见的并发症，而动脉粥样硬化（AS）是该类疾病重要的病理基础。近年来大量研究证实，高同型半胱氨酸血症（hyperhomocysteinemia．HHcy）是AS和血栓性疾病的一个新的、重要的、独立的危险因素。而终末期肾病患者存在高同型半胱氨酸血症。
作者 侯建乐 周健美
机构地区 安徽省皖南医学院附属弋矶山医院血液净化中心
出处 《岭南急诊医学杂志》 2010年第4期354-354,F0003,共2页 Lingnan Journal of Emergency Medicine
关键词 血液透析患者 血浆同型半胱氨酸 高同型半胱氨酸血症 维持性血液透析 心脑血管疾病 动脉粥样硬化 血栓性疾病 病理基础
分类号 R459.7 [医药卫生—急诊医学]
  • 相关文献

参考文献16

  • 1Mc Cully KS.Homocysteine and vascular disease.Nat Med,1996,2(4):386.
  • 2Welch GN,Loscalzo JN.Homocysteine and atherothrombosis.N Engl J Med,1998,338(15):1042.
  • 3Puddu P.Homocysteine and risk for atherothrombotic event.Cardiologia,1999,44(7):627.
  • 4Frank MF.Hyperhomocysteinemia:A million ways to lose control.Arterioscler Thromb Vasc Biol,2003,23(3):371.
  • 5Ungvari Z,Csiszar A,Edwards JG,et al.Increased superoxide production in coronary arteries in hyperhomocysteinemia:role of tumernecrosis factor-α,NADPH oxidase and inducible nitric oxidesynthase.Arterioscler Thromb Vasc Biol,2003,23(3):418.
  • 6Fichtlscherer S,Rossig L,Breuer S,et al.Tumor necrosis factor antagonism with etanercept improves systemic endothelial vasoreactivity in patients with advanced heart failure.Circulation,2001,104(25):3023.
  • 7Faraci FM,Lentz SR.Hyperhomocysteinemia,oxidative stress,and cerebral vascular dysfunction.Stroke,2004,35(2):345.
  • 8James SJ,Melnyk S,Pogribna M,et al.Elevation in S-adenosylhomocysteine and DNA hypomethylation:potential epigenetic mechanism for homocysteine-related pathology.J Nutr,2002,32(8 Suppl):2361S.
  • 9Hankey GJ,Eikelboom JW,Ho WK,et al.Clinical usefulness of plasma homocysteine in vascular disease.Med J Aust,2004,181(6):314.
  • 10Tsai JC,Perrella MA,Yoshizumi M,et al.Promotion of vascular smooth muscle cell growth by homocysteine:a link to atherosclerosis.Proc Natl Acad Sci USA,1994,91(14):6369.

二级参考文献34

  • 1叶云洁,倪兆慧,钱家麒,何颖欣.终末期肾病微炎症状态和动脉粥样硬化的关系[J].中华肾脏病杂志,2004,20(3):173-176. 被引量：94
  • 2彭侃夫,吴雄飞,赵洪雯,王军霞,吴亿,王殿珍,赵笑兰.连续性血液净化治疗多器官功能衰竭对Th1/Th2影响的临床研究[J].第三军医大学学报,2005,27(18):1877-1879. 被引量：14
  • 3陈朝生,徐玉兰,梅晓蓉,许菲菲,郑尘非,刘毅,王绿萍,黄朝兴.高通量血透对血浆同型半胱氨酸和超敏C反应蛋白的影响[J].中华肾脏病杂志,2006,22(8):506-507. 被引量：16
  • 4汤建明,王小兵,沈海花,苏凤珍,陆冬梅.连续性血液净化救治重症急性肾衰竭的护理[J].实用临床医药杂志（护理版）,2006,2(4):22-23. 被引量：3
  • 5Clarke B,Lewington S,Landray M.Homocysteine,renal function,and risk of cardiovascular disease[J].Kidney Int Suppl,2003,(84):S131-S133.
  • 6Cheung A K,Sarnak M J,Yan G,et al.Cardiac diseases in maintenance hemodialysis patients:resuit s of the HEMO Study[J].Kidney Int,2004,65(6):2380-2389.
  • 7Ducloux D,Motte G,Challier B,et al.Serum total homocysteine and cardiovascular disease occurrence in chronic,stable renal transplant recipients:a prospective study[J].J Am Soc Nephrol,2000,11(1):134-137.
  • 8Nishizawa Y,Shoji T,Maekawa K,et al.Intima-media thickness of carotid artery predicts cardiovascular mortality in hemodialysis patients[J].Am J Kidney Dis,2003,41(3 Suppl 1):S76-S79.
  • 9Edirimanne V E,Woo C W,Siow Y L,et al.Homocysteine stimulates NADPH oxidase-mediated superoxide production leading to endothelial dysfunction in rats[J].Can J Physiol Pharmacol,2007,85(12):1236-1247.
  • 10Perna A F,Ingrosso D,Lombardi C,et al.Possible mechanisms of homocysteine toxicity[J].Kidney Int Suppl,2003,(84):S137-S140.

共引文献50

同被引文献32

  • 1刘燕萍,郑法雷.尿毒症患者血管钙化机制的研究进展[J].世界医学杂志,2004,8(13):7-10. 被引量：2
  • 2Block G, Port FK. Calcium phosphate metabolism and car- diovascttlar disease in patients with chronic kidney disease. Semin Dial, 2003, 16: 140-147.
  • 3Raggi P, Boulay A, Chasan-Taber S, et al. Cardiac calcifi- cation in adult hemodialysis patients. A link between end- stage renal disease and cardiovascular disease? J Am Coll Cardiol, 2002, 39: 695-701.
  • 4Klassen PS, Lowrie EG, Reddan DN, et al. Association be- tween pulse pressure and mortality in patients undergoing maintenance hemodialysis. JAMA, 2002, 287: 1548- 1555.
  • 5Reynolds JL, Joannides A J, Skepper JN, et al. Human vas- cular smooth muscle ceils undergo vesicle-mediated calcifica- tion in response to changes in extracellular calcium and phos- phate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol, 2004, 15 : 2857-2867.
  • 6Moe SM, Chen NX. Pathophysiology of vascular calcification in chronic kidney disease. Circ Res, 2004, 95: 560-567.
  • 7Ketteler M, Bongartz P, Westenfeld R, et al. Association of low fetuin-A (AHSG) concentrations in serum with cardiovas- cular mortality in patients on dialysis: a cross-sectional study. Lancet, 2003, 361: 827-833.
  • 8Moe SM, Reslerova M, Ketteler M, et al. Role of calcifica- tion inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD). Kidney Int, 2005, 67: 2295-2304.
  • 9Raggi P, Boulay A, Chasan-Taber S, et al. Cardiac calcifi- cation in adult hemodialysis patients. A link between end- stage renal disease and cardiovascular disease? J Am Coil Cardiol, 2(102, 39: 695-701.
  • 10Jono S, McKee MD, Murry CE, et al. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res, 2000, 87: E10-E17.

引证文献2

二级引证文献5

岭南急诊医学杂志
2010年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部